If you would like to ask our webinar guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFusion Antibody Share News (FAB)

Share Price Information for Fusion Antibody (FAB)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3.40
Bid: 3.30
Ask: 3.50
Change: 0.00 (0.00%)
Spread: 0.20 (6.061%)
Open: 3.40
High: 3.40
Low: 3.40
Prev. Close: 3.40
FAB Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AIM WINNERS & LOSERS: Cornerstone FS to beat 2023 expectations

Mon, 04th Dec 2023 10:23

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Monday.

----------

AIM - WINNERS

----------

Cornerstone FS PLC, up 26% at 14.48 pence, 12-month range 5.30p-18.50p. The cloud-based payment services provider predicts 2023 adjusted earnings before interest, tax, depreciation and amortisation "materially above current market expectations". "I am pleased to be able to report that we are continuing to experience excellent trading momentum. This reflects the actions that we have taken during the year to enhance our sales team and expand our offer, such as by broadening the range of currencies and countries where we can transact," Chief Executive Officer James Hickman said.

----------

Deltex Medical Group PLC, up 19% at 0.18 pence, 12-month range 0.14p-1.60p. The maker of blood circulation monitoring systems says testing of its TrueVue monitor "has gone to plan" in recent months. "The first in market sale of the new TrueVue monitor was completed at the end of November 2023. In addition, the company has received initial orders for new TrueVue monitors, which it expects to fulfil over the coming months," Deltex adds.

----------

AIM - LOSERS

----------

Fusion Antibodies PLC, down 25% at 4.38p, 12-month range 3.02p-70.00p. The contract research organisation, providing discovery, design and optimisation services for therapeutic antibodies to the healthcare market, reports weaker half-year earnings. Revenue falls to GBP541,000 in the six months to September 30, from GBP1.9 million a year prior. Its pretax loss widens to GBP1.4 million from GBP1.3 million. However, Fusion Antibodies is "confident" that its growth prospects are "increasingly positive", noting that it expects full-year revenue to be "significant weighted towards" the second half of the year ending on March 31.

----------

By Eric Cunha, Alliance News news editor

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
6 Dec 2021 14:54

IN BRIEF: Fusion Antibodies loss widens on administrative expenses

IN BRIEF: Fusion Antibodies loss widens on administrative expenses

Read more
6 Dec 2021 11:59

Revenues rise, losses widen for Fusion Antibodies

(Sharecast News) - Contract preclinical antibody research provider Fusion Antibodies reported revenues of £2.4m in its first half on Monday, including a one-off milestone of £0.15m, which was up from £1.9m year-on-year.

Read more
2 Dec 2021 22:01

TRADING UPDATES: SRT Marine Systems and ULS Technology losses widen

TRADING UPDATES: SRT Marine Systems and ULS Technology losses widen

Read more
29 Nov 2021 16:08

UK earnings, trading statements calendar - next 7 days

UK earnings, trading statements calendar - next 7 days

Read more
7 Oct 2021 12:11

IN BRIEF: Fusion Antibodies signs USD1.8 million biotech contract

IN BRIEF: Fusion Antibodies signs USD1.8 million biotech contract

Read more
7 Oct 2021 11:59

Fusion Antibodies signs collaborative deal with US biotech firm

(Sharecast News) - Preclinical antibody discovery and supply company Fusion Antibodies has signed a collaborative research and development agreement with an unnamed US-based biotechnology company which was recently incorporated to focus on a number of innovative early-stage antibody programmes, it announced on Thursday.

Read more
24 Sep 2021 11:55

Fusion Antibodies performing in line in year-to-date

(Sharecast News) - Antibody discovery, engineering and supply company Fusion Antibodies said on Friday that revenue growth in the current year had been consistent year-on-year, and in line with its expectations.

Read more
24 Sep 2021 11:01

TRADING UPDATES: Iofina interim profit doubles on higher iodine sales

TRADING UPDATES: Iofina interim profit doubles on higher iodine sales

Read more
17 Sep 2021 16:08

UK shareholder meetings calendar - next 7 days

UK shareholder meetings calendar - next 7 days

Read more
24 Aug 2021 12:35

TRADING UPDATES: IG Design starts year well; Ilika in Stereax progress

TRADING UPDATES: IG Design starts year well; Ilika in Stereax progress

Read more
10 Aug 2021 14:01

IN BRIEF: Fusion Antibodies shares fall after annual loss widens

IN BRIEF: Fusion Antibodies shares fall after annual loss widens

Read more
10 Aug 2021 12:44

Revenues rise, losses widen for Fusion Antibodies

(Sharecast News) - Preclinical antibody discovery specialist Fusion Antibodies reported a 7% improvement in full-year revenues in its final results on Tuesday, to £4.2m.

Read more
23 Jul 2021 19:20

TRADING UPDATES: Parsley Box's new meal range; Macau Property NAV down

TRADING UPDATES: Parsley Box's new meal range; Macau Property NAV down

Read more
23 Jul 2021 09:32

Fusion Antibodies receives first research milestone payment

(Sharecast News) - Preclinical antibody discovery, engineering and supply company Fusion Antibodies has achieved its first research milestone payment as part of its ongoing collaboration with a major client, it announced on Friday.

Read more
4 May 2021 19:13

TRADING UPDATES: Supreme annual revenue jumps; Pelatro in Asia deal

TRADING UPDATES: Supreme annual revenue jumps; Pelatro in Asia deal

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.